2007) Although these are endorsed goals they are no t always appropriate for all patients-in some patients the 7% or less or 6.5% or less standard presents too great a risk of hypoglycemia with its concomitant complications. In these instances, a clinician may negotiate with the patient to set a different, higher goal to optimize patient safety and care.
For this study, A1C was used as an indicator of the quality and effectiveness of the Iowa City VAHCS's aggressive case management CCHT program, with a baseline measure taken immediately before each patient is offered entry into the program and at regular intervals thereafter. We thus proposed to evaluate the quality of the CCHT program using long-term serum glucose control as our primary outcome. See Table 1 for a description of measurement points.
This program effectiveness study was focused on a case management/home telemonitoring program that has been underway for almost 5 years. The program actively recruits patients with A1C level of 9% or more (212 mg/dl; mmol/L). Program participants must also have standard plain old telephone service (POTS), adequate elec trical service to their homes, and be willing and physical ly able to participate in the program. Patients are identifi ed through a diabetes registry, direct referral from providers, and through monitoring of Endocrine Clinic appointments. Case managers expend extensive effort contacting providers to inform them that this program is available to patients. Once patients are identifi ed, they are contacted by a case manager to confi rm eligibility through the use of a standard questionnaire. See Table 2 for a summary of admission criteria.
Because this program is an active service provided to all qualifi ed patients, randomized selection of a control group was not possible. Instead, those patients who met the health criteria for admission to the program and were either unwilling or unable to participate, due to a lack of POTS or electrical service, serve as a control. No demographic data were recorded-thus, it is impossible to detail the comparability of the control group versus the intervention group. We use three groups in this analysis: a nonrandomized control group that did not receive the intervention, a nonrandomized intervention group of current program participants, and a nonrandomized intervention group of program graduates.
For the purposes of this program evaluation, we consider all program participants as a single intervention group, and for some analyses, divide them into two subgroups: program graduates and current participants.
INTERVENTION PROGRAM DESCRIPTION
The VHA model of case management and home telemonitoring (Darkins et al., 2008) has been implemented been shown to be effective. Furthermore, some studies strongly suggest that aggressive case management combined with home telemonitoring is more effective than either component separately (Barnett et al., 2007; Darkins et al., 2008) . In 2006, the Iowa City VA Health Care System (VAHCS) initiated an aggressive case management Care Coordination/Home Telehealth (CCHT) program with the goal of assisting veteran patients with diabetes through continuous education and active assistance with long-term serum glucose control.
The objective of this study is to evaluate the quality of an established case management/home telemonitoring program using health outcome as the determinate of program effectiveness.
MEASURES AND METHODS
Although daily monitoring of blood glucose levels plays a critical role in helping patients with diabetes manage their health in the short term, stable and reliable measurement of glucose control over the longterm is possible through the use of hemoglobin A1C (A1C) levels (American Diabetes Association, 2010).
A1C testing measures the level of glycosylated hemoglobin molecules in blood cells over a period of 4 to 12 weeks. Thus, the A1C test gives clinician and patients an overall view of average glucose control for that period. The American Diabetes Association maintains that an A1C goal of 7% or less (estimated average serum glucose level of 154 mg/dl; 8.6 mmol/L) for patients with diabetes offers the greatest protection from diabetes complications, including reducing microvascular and neuropathic complications (nephropathy and retinopathy) and reducing the incidence of cardiovascular disease (American Diabetes Association, 2010). The American Association of Clinical Endocrinologists recommends attainment of a more ambitious A1C goal of 6.5% or less (estimated average serum glucose level of 140 mg/dl; 7.75 mmol/L) to achieve the greatest protection from diabetes complications (Rodbard et al., with the new orders or questions about their status. Case managers also use this opportunity to further supplement and support diabetes education previously provided to the patient.
As part of the normal program process, A1C tests are ordered in conjunction with regular clinic visits. Patients are evaluated using A1C level at admission, 3 months postadmission, 6 months postadmission, and at the 1-year mark. The general guideline is for patients to achieve their targeted goal expressed in terms of A1C.
After 1 year of the intervention, if the patient has met the program self-management goals negotiated during initial assessmen t, they are "graduated" from the program. Procedure at graduation includes presentation of a certifi cate from the case manager and information on how to reestablish contact if conditions warrant. Case managers continue to monitor A1C for program graduates for at least another 2 years.
at the Iowa Cit y VAHCS to provide for aggressive case management and daily monitoring for veteran patients whose health is at risk from poorly controlled diabetes. For each patient, the program is designed to continue for 12 consecutive months, although it can continue for a longer period, depending upon the judgment of the provider as informed by the case manager. Program participants agree to use home telehealth equipment (manufactured by Vitel Net) to send required data to a secure server and answer disease related interrogatories on a daily basis (the precise wording of these questions may be found in Appendix A). Failure to fulfi ll these obligations can result in discharge from the case management/home monitoring program.
Upon enrollment, Registered Nurse (RN) case managers educate the patients face-to-face on the use of their assigned home telemonitoring equipment and ask the enrollees to demonstrate competency. During the same face-to-face interaction, participants also receive individualized diabetes education relevant to their specifi c needs. Every nonholiday weekday for the ensuing 12 months, patients transmit data including blood glucose levels (in mg/dl), weight , and blood pressure to a secure server, which is subsequently accessed by a nurse/case manager who reviews these data for variance from expectations. Expectations for transmitted health data are determined for each patient by the treating physician in combination with the RN case manager. When discrepancies are noted (e.g., blood glucose levels out of range, changes in weight or blood pressure, unexpected responses to daily interrogatories), the case manager judges whether to contact the responsible provider for orders or to call the patient directly to better evaluate the patient's status. In either event, the patient is contacted by the case manager either 
TABLE 2
Summary of Admission Criteria (higher A1C) trend thereafter, stands in sharp contrast with the performance of program participants. For the intervention group, there were signifi cant reductions through 12 months, with stable A1C levels thereafter.
The case management process in this intervention is demand driven-after initial patient contact for education and so on, case managers contact participants when telemonitoring equipment indicates that daily clinical parameters exceed parameters established by their care team. There is some evidence in the literature that frequency and duration of case manager contact is associated with positive outcomes (Pimouguet, Le Goff, Thiebaut, Dartigues, & Helmer, 2011) . In this program, to the extent that frequency and duration of contact are a function of patient health status, it may be reasonable to suggest that telemonitoring clinical data transmitted on a daily basis serves as a case manager's workload "regulator" in that case managers can choo se to make contact only when a patient's vitals are out of acceptable parameters. By extension, enrolled participants' case management dosage may be "just right" in that it meets the patients' minimum requirements to achieve positive health outcomes.
The statistically signifi cant differences between the graduate subgroup and the current participant subgroup are diffi cult to interpret. It is possible that the reason participants are currently in the program is the very fact that they have not achieved their negotiated goals, which explains their higher mean A1C. Our data reveal no insight in this regard. It is also possible that this phenomenon-the content of the interchange between the case manager and the patient differs in some way-is case manager dependent. Thus, some of those patients currently in the program respond to their case managers in a manner that is less effective in controlling their blood glucose levels. Again, the data gathered for this study do not allow us to investigate this possibility.
LIMITATIONS OF THE STUDY
There are a number of shortcomings in this observational retrospective design. None of these subjects were randomly assigned and the population consisted entirely of veteran patients who share many of the same demographic characteristics. Furthermore, the intervention group was limited to those who had POTS in their homes, effectively excluding those who use exclusively wireless phones. We also chose not to record patient demographic characteristics, which weakens our analysis and precludes review for comparability of data that might have allowed us to distinguish a bias in our method of selection. In addition to these shortcomings, this study lacks a cost-benefi t The average number of participants managed by a single case manager ranges from 70 to 80 patients. A large number of those who are not graduated from the program after 1 year may have achieved targeted diabetes goals, but remain in the case management/home telemonitoring program for unrelated reasons (e.g., functional status, cognitive status, multiple comorbidities). In addition, those who continue to demonstrate problems with diabetes self-management or do not meet program goals, may also remain in the program. The other program participants are a fl uid panel of patients, revolving through the program by admission and successful discharge (see Appendix B for program discharge criteria), not requiring continued home telemonitoring and aggressive case management to maintain the targeted diabetes goals. Table 3 displays the timeline and mean A1C levels for the control group and the intervention groups (program graduates, current participants, and their aggregate). Analysis of variance shows that, with no signifi cant difference in mean A1C between groups at the beginning of the study period, statistically signifi cant differences (95% CI; p Ͻ .001) between the control and aggregate intervention groups are evident from t + 3 months through t + 36 months. Comparison of the fi rst two data columns illustrates the differences in means (95% CI; p Ͻ .001) between the intervention subgroups. Although A1C control differs signifi cantly between the two intervention subgroups, both remain signifi cantly distinguishable from the control. The median A1C for the program graduate group reaches the ADA-recommended guideline of A1C goal of 7% or less from t ϩ 6 months forward, whereas the median for other groups does not.
RESULTS
Analyzing within group changes over time, the program graduate subgroup shows signifi cant progress from t through t + 12 months, stabilizing at or near the ADA-recommended target A1C of 7% or less (154 mg/dl; 8.6 mmol/L). Similarly, the current participant group shows signifi cant progress through the same period, although the mean A1C did not reach the 7% or less mark. The control group, in isolation, shows a signifi cant mean reduction in A1C of 1.2% at t + 3 months, but no signifi cant change thereafter.
DISCUSSION
These data are evidence of the effectiveness of home telemonitoring paired with aggressive case management. The performance of the control group, which showed a signifi cant A1C reduction in the fi rst 3 months of the program, but a steady upward most likely to be diagnosed with diabetes, use only wireless phones (Blumberg et al., 2009 ).
There are three technological approaches to solve this dilemma:
1. The use of interactive voice response using a cell phone for manual input of health data (blood glucose, weight, or blood pressure), 2. The adaptation of home telehealth units to use wireless signals to communicate with servers as landline phones do now, and 3. The use of a personal computer interface that acts as the home terminal and communicates data to the server. A comparative study of these three technologies as part of a case management/home telemonitoring program would assist health care decision makers in making appropriate choices to improve the quality (and quantity) of programs like this.
Furthermore, although there is some evidence ) that case management with daily telemonitoring is more effective than less frequent telemonitoring. A comparative study of these different interactive methods, carefully logging and noting the content of communications between case manager and patient could provide even more insight into the process and give managers the information they need when making choices about program adoption and process improvement. There is an important opportunity for collaboration in further developing research into case management with home telemonitoring, analysis. Clearly, there are signifi cant start-up costs in establishing a home telemonitoring programthe cost of the in-home equipment alone can range from $1,000 to $5,000 per patient and the average RN case manager's salary in the U.S., $67,720 (Occupational Employment Statistics, 2010) as of May 2010, signifi cantly increases these costs. This study did not include a return-on-investment analysis, and although others have looked at the value of such a regime using a variety of metrics to assess its value Chumbler, Vogel, et al., 2005) more research and analysis in this area is required.
DIRECTION FOR FURTHER STUDY
The control group for this study comprises patients who did not enter the program, either because they had no landline phone or they simply chose not to participate. For this particular group of patients further exploration of barriers to their care should be investigated. Of particular interest is the incorporation of wireless technology into the home monitoring regimen: as many as 10% of those in this study's control group indicated they could not participate because they had no POTS, and the latest estimates indicate that 23% of adults have only cellular service in their homes, a portion of the population that is continually increasing. As of 2009, an estimated 15% of those in the 45-64 age group, the cohort and such an effort should involve the U.S. military treatment facilities and private contractors who also provide analogous services to active duty military and civilian patients. Such a collaborative study, with a signifi cantly larger number of patients, will substantially increase our knowledge in this understudied area. Finally, disentangling the infl uence of case management from the effect of home telemonitoring should be a quality improvement research priority. Telemonitoring, although becoming less costly over time, is an expensive proposition with expensive equipment, and there is not an abundance of evidence indicating that case management is improved when it is used in conjunction with home telemonitoring. Although the case management literature is somewhat more developed than that for telemonitoring, there are suffi cient lacunae in both areas that further investigation is required regarding the content, duration, and frequency of case managers' communications with patients and the effectiveness of telemonitoring in isolation.
Nonetheless, these fi ndings that patients have greater long-term A1C control when they participate in this particular case management/home telemonitoring program provide support for continuance of the program. Such a regimen gives case managers the opportunity to make frequent, on-demand contact with patients to provide support, comprehensive diabetes education, lifestyle advice, and also may expedite interaction with providers to facilitate aggressive medication management, all of which contribute to optimal diabetes outcomes.
